Kinnate Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.8%.

Top 25 shareholders own 79.43% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
28%	Foresite Capital Management, LLC	13,197,600	€31.3m	0%	6.68%
17%	OrbiMed Advisors LLC	8,009,729	€19.0m	0%	0.25%
5.52%	Tang Capital Management, LLC	2,601,647	€6.2m	0%	0.54%
4.69%	Vida Ventures Advisors, LLC	2,207,772	€5.2m	0%	1.85%
4.24%	Lynx1 Capital Management LP	1,997,006	€4.7m	0%	1.38%
3.86%	Viking Global Investors LP	1,820,462	€4.3m	0%	0.01%
2.21%	The Vanguard Group, Inc.	1,042,910	€2.5m	4.9%	no data
1.76%	Acadian Asset Management LLC	830,493	€2.0m	12.7%	0.01%
1.25%	BlackRock, Inc.	586,688	€1.4m	-20.9%	no data
1.22%	Renaissance Technologies LLC	574,979	€1.4m	13.6%	no data
1.2%	Millennium Management LLC	564,932	€1.3m	1.38%	no data
1.2%	Group One Trading LP, Asset Management Arm	563,565	€1.3m	188,000%	0.04%
0.99%	BML Capital Management, LLC	468,210	€1.1m	0%	0.69%
0.88%	Citadel Advisors LLC	415,842	€985.3k	-60.8%	no data
0.79%	GSA Capital Partners LLP	374,291	€886.8k	0%	0.07%
0.75%	Susquehanna International Group, LLP, Asset Management Arm	354,569	€840.1k	144%	no data
0.64%	Two Sigma Investments, LP	299,633	€709.9k	118%	no data
0.62%	Acuitas Investments, LLC	289,766	€686.6k	0%	0.23%
0.49%	Geode Capital Management, LLC	230,753	€546.7k	4.17%	no data
0.47%	Pale Fire Capital SE	220,555	€522.6k	214%	0.07%
0.41%	Marshall Wace LLP	194,468	€460.8k	131%	no data
0.33%	Goldman Sachs Group, Investment Banking and Securities Investments	156,226	€370.2k	97.8%	no data
0.32%	Two Sigma Advisers, LP	153,000	€362.5k	43%	no data
0.32%	D. E. Shaw & Co., L.P.	150,695	€357.0k	170%	no data
0.24%	Dws Investment Gmbh	114,846	€272.1k	0%	no data